Proceedings of IMPAACT Annual Meeting 2021 Now Online

Date: 06/30/2021

Publication:

impaactannualmeeting.org

Summary

Convened June 22-24, 2021, the 2021 virtual meeting of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network highlights the latest updates and exciting science in the field, and includes sessions from JHUBI-CTU Co-PIs Drs. Amita Gupta and Charles Flexner.

View Video Presentations

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

A5290, A Randomized, Phase 2b Study of a Double-Dose...

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

A5253: Sensitivity and Specificity of Mycobacterium...

An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...

P1073: Study of Immune Reconstitution Inflammatory Syndrome...

P1073 is a case controlled prospective, clinical, observational and pathogenesis study of HIV-infected infants and children...